Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI
Maina, A, Arrotta, M, Cicogna, L, Donvito, V, Mischinelli, M, Todros, T, Rivolo, S
Published in BJOG : an international journal of obstetrics and gynaecology (01.11.2014)
Published in BJOG : an international journal of obstetrics and gynaecology (01.11.2014)
Get full text
Journal Article
462P Health outcomes of treatment sequences with eribulin or other single agents’ chemotherapy for treating relapsed metastatic HER2-negative breast cancer
Rivolo, S., Ndirangu, K., Teloian, D., Ambavane, A., Jackisch, C., Hall, P.S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1626O - ESMO-MCBS and health technology assessment (HTA): Does value for physicians correspond to value for payers?
Ambavane, A., Benedict, A., Rivolo, S., Rakonczai, P., Kapetanakis, V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
ESMO-MCBS and health technology assessment (HTA): Does value for physicians correspond to value for payers?
Ambavane, A., Benedict, A., Rivolo, S., Rakonczai, P., Kapetanakis, V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1626OESMO-MCBS and health technology assessment (HTA): Does value for physicians correspond to value for payers?
Ambavane, A, Benedict, A, Rivolo, S, Rakonczai, P, Kapetanakis, V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
EE29 Clinical and Economic Impact of Pre-Exposure Prophylaxis With Tixagevimab+Cilgavimab in 2022 in Switzerland to Protect Immunocompromised Individuals
Rivolo, S., Bungey, G., Morris, W., Nagy, E., Williams, S., Maillat, L., Jańska, A., Arnetorp, S.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
EE27 Cost-Effectiveness and Cost-Utility Analysis of Somatrogon Once-Weekly Injectable vs Daily Growth Hormones for Treating Pediatric Growth Hormone Deficiency
Rivolo, S, Loftus, J, Peter, B, Fahey, M, Toghanian, S, Peral, C, Khanji, C, Stewart, M, Kongnakorn, T
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
9 The mechanics of cardiac contraction and coronary flow: exercise, ischaemia and anti-anginals
Patterson, T, Rivolo, S, Arri, S, Perera, D, Clapp, B, Marber, M, Lee, J, Redwood, S
Published in Heart (British Cardiac Society) (01.05.2016)
Published in Heart (British Cardiac Society) (01.05.2016)
Get full text
Journal Article
PIN63 - A COST-MINIMIZATION MODEL TO EVALUATE THE IMPACT OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN HOSPITALIZED ADULTS IN SPAIN
Soriano, A., Grau, S., Rivolo, S., Remak, E., Peral, C., Kantecki, M., Ansari, W., Charbonneau, C., Hammond, J., Wilcox, M.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
Torres, Antoni, Soriano, Alex, Rivolo, Simone, Remak, Edit, Peral, Carmen, Kantecki, Michal, Ansari, Wajeeha, Charbonneau, Claudie, Hammond, Jennifer, Grau, Santiago, Wilcox, Mark
Published in ClinicoEconomics and outcomes research (01.01.2022)
Published in ClinicoEconomics and outcomes research (01.01.2022)
Get full text
Journal Article
PNS32 AUTOMATIC ABSTRACT SCREENING USING MACHINE LEARNING TECHNIQUES: ARE WE THERE YET AND HOW CAN WE MOVE FORWARD?
Rivolo, S., Marczell, K., Dillon-Murphy, D., Sarri, G., Benedict, Á.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article